3 assets in Pulmonary Emphysema

Therapeutic assets addressing Pulmonary Emphysema, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
ce1226 Pulmonary Emphysema	CSL Behring	P4	BB (65)
.Alpha.-1 Protease Inhibitor Pulmonary Emphysema	Sanofi	P2	B (62)
sar447537 Pulmonary Emphysema	Sanofi	P2	B (57)